“…It appears that this protocol can be safely used to inhibit PBel CGRP neurons repeatedly with an interval of 5 min between inhibition trials, because there was no histological damage to the brain after laser exposure and because the animals had normal CO2 arousal during Laser-OFF trials performed after Laser-ON trials. ArchT has been used to silence neurons in vivo in a wide variety of recent studies (Boada et al, 2014;Campos et al, 2016;Daou et al, 2016;Kim et al, 2015;Shi et al, 2015;Stefanik et al, 2013;Stefanik and Kalivas, 2013;Tsunematsu et al, 2013), and this use has also been validated by extracellular recordings from neocortical areas (Chow et al, 2010;Chuong et al, 2014). It has recently been reported that ArchT activation may excite some terminals (Mahn et al, 2016) instead of inhibiting them, but that is unlikely to be the case in these experiments, as the results of using ArchT to inhibit the PBel CGRP terminals in the forebrain were very similar to those for using ArchT to inhibit the CGRP cell bodies in the PBel, and both were similar to the results of deleting Vglut2 from PBel CGRP neurons, or ablating them genetically (Kaur et al, 2013).…”